Swiss Structures

Swiss Structures Justin Hession Photography /1 in September 2006, it led to a complete rethinking of ABC transporter structure - and the retraction of five earlier papers on related structures.2 (A software error had led Geoffrey Chang, the young US researcher who had published those earlier articles, to inadvertently mistake the handedness of the molecule.) Locher, a steely character with short dark hair and rimless glasses, suggests that Chang's blunder

Written byStephen Pincock
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Locher, a steely character with short dark hair and rimless glasses, suggests that Chang's blunder might have been a result of rushing. Even if you are racing to the synchrotron, you must still adopt an almost obsessive caution, Locher says. "Perhaps you have to be a bit of a nerd," he laughs. "You have to be the kind of guy who would stand in front of a dart board and not leave until you throw a triple twenty."

In 2006 and 2007, Locher's publication was just one of nine that the institute's structural biologists landed in Science and Nature, in which they reported the structures of several important molecules, including fatty acid synthases from mammals and fungi. These papers were among the 300 refereed publications by the Department of Biology's employees in that period, according to ETH.

Several floors upstairs from Locher's office, Croatian researcher Nenad Ban agrees that diligence ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies